MapmyGenome selected among the top seven finalists for Wall Street Journal’s Annual Startup Showcase.

MapmyGenome Selected Among the Top Seven Finalists for Wall Street Journal’s Annual Startup Showcase

MapmyGenome is proud to share its nomination in the prestigious Wall Street Journal Startup Showcase — and is the only Indian company to be selected in this illustrious list.

The Startup Showcase finalists are selected by The Wall Street Journal’s senior editors from entries across the world. Entry into this elite list is an honour by itself, with the platform guaranteeing exposure and recognition for the entrepreneurs and their business.

The Finalists

• Anuradha Acharya | CEO, MapmyGenome India

• Ladislas de Toldi | CEO, Leka Inc.

• Thibault Duchemin | Founder and CEO, Ava

• Suman Kanuganti | Co-Founder and CEO, Aira

• Franck Nazikian | Co-Founder and CEO, WowTune

• Daniel Shani | Founder and CEO, Energy Intelligence

• Duleek Ranatunga | CEO, Ourotech

The finalists were offered an opportunity to present their companies to a panel of judges and an audience of Fortune 500 CEOs, entrepreneurs, and investors from around the world. The esteemed judges’ panel included Kate Hudson (Co-Founder, Fabletics), Rupert Murdoch (Executive Chairman, News Corp and 21st Century Fox), Theresia Gouw (Co-Founder and Managing Partner, Aspect Ventures), and Nick Woodman (Founder and CEO, GoPro).

About MapmyGenome

Founded in 2013, MapmyGenome started as India’s pioneering Genomics Company with a vision to “Touch 100 million lives and save a million lives by 2030.” Headquartered in Hyderabad, India, MapmyGenome offers personalised health solutions based on genetic tests that help people get to know about themselves. By combining genetic health profile and health history with genetic counselling, MapmyGenome provides actionable steps for individuals and their physicians towards a healthier life.